Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Polycystic Ovary Syndrome 41Obesity 9Anovulation 8Infertility 7Insulin Resistance 6Overweight 2Non-alcoholic Fatty Liver Disease 2Hirsutism 2Diabetes, Gestational 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Nodule 1Racism 1Prostatic Neoplasms 1Pregnancy Complications 1Mouth Neoplasms 1Metabolic Syndrome 1Hyperandrogenism 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Dyslipidemias 1Diabetes Mellitus, Type 2 1Breast Cancer Female 1Body Weight 1Amenorrhea 1Acne Vulgaris 1

Interventions

Rocuronium 2Ofloxacin 2Mitomycin 25-aminolevulinic acid hexyl ester 2remimazolam 1penpulimab 1pembrolizumab 1mebeverine 1lornoxicam 1enfortumab vedotin 1disitamab vedotin 1Ultrasonography 1Trimethoprim, Sulfamethoxazole Drug Combination 1Tobacco Use Cessation Devices 1Tamsulosin 1Sugammadex 1Specimen Handling 1Psychiatric Rehabilitation 1Propofol 1Polymerase Chain Reaction 1Nitrofurantoin 1Neuromuscular Blockade 1Neuroleptanalgesia 1Nephroureterectomy 1Neostigmine 1Midazolam 1Metformin 1Mepivacaine 1Magnetic Resonance Spectroscopy 1Levofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Urinary Bladder Neoplasms × Metformin × Clear all
NCT06215976 2024-08-20

The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer

Cairo University

Phase 4 Recruiting
78 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡